| We are different. Everyone in the industry is talking about how their product can deliver small particles. That's not too difficult, but it severely limits their efficacy, range, and flexibility. Today, our products are designed to deliver small particles as well as the large particles. DDS has the ability to deliver actives that are potentially thousand times larger than those found in other topical delivery systems. We do this for you because not all molecules you compound with come in short chains. Our DDS (Derma Delivery System(TM)) enhances the speed and depth of penetration of various API's. DDS is a revolutionary vesicle that is capable of: o Delivering small, medium, and large molecules. o Delivering large volumes of actives into the skin. o Delivering deep into the dermis. o Delivering whole molecules to the target zone. We use real science. |
| The right amount to the right place at the right speed. The ideal delivery system would deliver to the target site and at rate dictated by the need of the body. That's our goal. Our research continues to successfully incorporate multiple symbiotic vesicle systems to further optimize the skin penetration and bioavailability. We have significantly improved the entrapment efficiency, particle size, zeta potential, stability, and skin permeability. Our research continues with various vesicular systems that can be used as carriers of amphiphilic and lipophilic actives and improve the therapeutic index. The physiochemical characteristics we seek to make continuous improvement include: o an infrastructure consisting of hydrophilic, amphiphilic and lipophilic moieties that can accommodate active molecules with a wide range of solubilities. o vesicles that can act as a depot, releasing the actives in a controlled manner. o a medium that is osmotically active and stable, as well as increasing the stability of entrapped actives. o easy storage conditions and stable over a long period. o improved bioavailability and skin penetration of actives. |
Faster delivery.
The skin acts as a major target as well as
a principle barrier. The stratum corneum
plays an important role as barrier.
Despite major research and development
efforts, low stratum corneum permeability
limits the usefulness of topical delivery.
To overcome this, methods have been
assessed to increase permeation.
Different vesicular systems have been
intensely researched using liposomes,
proliposomes, follicular transport,
niosomes, and nano technology. But
effectiveness of all these methods
depends on their physicochemical
properties.
One of our continued research areas is to
provide a delivery system for the general
topical administration of medications
which is protective of the target skin
surface.
Today our products offer high
performance. Our aim is to further
enhance the depth and speed of
penetration.
We deliver.
Other technologies allow only a very small
percentage of actives to be absorbed.
Our DDS can deliver large volumes of
actives into the skin. DDS employs a
megasphere technology that does not
require a separate carrier or penetration
enhancer. As a result, DDS is able to
deliver ten times more actives.
Other delivery systems can deliver only
small volumes of small molecules to the
skin. These processes cause the
delivered molecules to frequently break
down and denigrate as they attempt to
cross the skin barrier. DDS solves this
major deficiency by using a megasphere
mechanism that encapsulates both the
agent and carrier thus, delivers both as a
whole.
The skin acts as a major target as well as
a principle barrier. The stratum corneum
plays an important role as barrier.
Despite major research and development
efforts, low stratum corneum permeability
limits the usefulness of topical delivery.
To overcome this, methods have been
assessed to increase permeation.
Different vesicular systems have been
intensely researched using liposomes,
proliposomes, follicular transport,
niosomes, and nano technology. But
effectiveness of all these methods
depends on their physicochemical
properties.
One of our continued research areas is to
provide a delivery system for the general
topical administration of medications
which is protective of the target skin
surface.
Today our products offer high
performance. Our aim is to further
enhance the depth and speed of
penetration.
We deliver.
Other technologies allow only a very small
percentage of actives to be absorbed.
Our DDS can deliver large volumes of
actives into the skin. DDS employs a
megasphere technology that does not
require a separate carrier or penetration
enhancer. As a result, DDS is able to
deliver ten times more actives.
Other delivery systems can deliver only
small volumes of small molecules to the
skin. These processes cause the
delivered molecules to frequently break
down and denigrate as they attempt to
cross the skin barrier. DDS solves this
major deficiency by using a megasphere
mechanism that encapsulates both the
agent and carrier thus, delivers both as a
whole.
HOME | COMPOUNDING BASES | DERMA DELIVERY SYSTEM(TM) | YOUR CUSTOM FORMULAS
WHO WE ARE | UNIQUE TECHNOLOGIES | QUALITY STANDARDS | FAQ | CONTACT US
WHO WE ARE | UNIQUE TECHNOLOGIES | QUALITY STANDARDS | FAQ | CONTACT US
Bioselect Innovations
THE ULTIMATE COMPOUNDING BASES (TM)
THE ULTIMATE COMPOUNDING BASES (TM)
POB 2413
CAPO BEACH, CA 92624
949.630.3844
HRT@HRTBASE.COM
CAPO BEACH, CA 92624
949.630.3844
HRT@HRTBASE.COM
| Bioselect Innovations hrtbase.com |
MANY FEATURES IN OUR PRODUCTS ARE PROTECTED BY PROPRIETARY
TECHNOLOGIES AND PATENTS IN THE U.S.A. AND OTHER COUNTRIES.
© 2010 BIOSELECT INNOVATIONS. ALL RIGHTS RESERVED.
TECHNOLOGIES AND PATENTS IN THE U.S.A. AND OTHER COUNTRIES.
© 2010 BIOSELECT INNOVATIONS. ALL RIGHTS RESERVED.
HOME | OUR POLICY | YOUR PRIVACY | GIVE MORE | CONTACT US